欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2196/001
药品名称
Pioglitazon Mylan
活性成分
pioglitazone 15.0 mg
剂型
Tablet
上市许可持有人
Mylan Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 04569/1245 - 0021
Italy (IT)
Czechia (CZ)
Pioglitazon Mylan (15 mg)
Greece (GR)
许可日期
2012/02/01
最近更新日期
2024/08/13
药物ATC编码
A10BG03 pioglitazone
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
Final Lab_Pioglitazone
Date of last change:2024/09/06
Final PL
|
Final PL_Pioglitazone
Date of last change:2024/09/06
Final SPC
|
Final SmPC_Pioglitazone
Date of last change:2024/09/06
PubAR
|
Pioglitazone_NPAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase